GeneDx Holdings Corp header image

GeneDx Holdings Corp

WGS

Equity

ISIN null / Valor 126808031

NASDAQ (2026-10-09)
USD 67.33-0.59%

GeneDx Holdings Corp
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

GeneDx Holdings Corp. (Nasdaq: WGS) is a company specializing in genomic insights to enhance health outcomes. The firm focuses on providing advanced genetic testing and diagnostic services, leveraging cutting-edge technology to offer precise and actionable genomic data. GeneDx's offerings are designed to support healthcare providers in diagnosing and managing a wide range of genetic disorders, thereby improving patient care and treatment strategies. The company is publicly traded and regularly reports its financial performance, with its latest results for the first quarter of 2024 scheduled for release after market close on April 29, 2024.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-46.9%1Y
1,978%3Y
-75.0%5Y

Performance

97.2%1Y
112%3Y
110%5Y

Volatility

Market cap

2008 M

Market cap (USD)

Daily traded volume (Shares)

405,115

Daily traded volume (Shares)

1 day high/low

77.8 / 73.985

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Madrigal Pharmaceuticals Inc
Madrigal Pharmaceuticals Inc Madrigal Pharmaceuticals Inc Valor: 33395434
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.08%USD 471.75
Orion Oyj
Orion Oyj Orion Oyj Valor: 2553360
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.99%EUR 79.70
Spire Healthcare Group PLC
Spire Healthcare Group PLC Spire Healthcare Group PLC Valor: 24881418
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.20%GBP 2.47
Curatis Holding Ltd
Curatis Holding Ltd Curatis Holding Ltd Valor: 133078097
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.76%CHF 19.70
Biogaia AB
Biogaia AB Biogaia AB Valor: 118922125
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.21%SEK 116.80
Inventiva SA
Inventiva SA Inventiva SA Valor: 35598121
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.14%EUR 2.86
Oncopeptides AB
Oncopeptides AB Oncopeptides AB Valor: 35671972
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
45.15%SEK 2.96
Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited Glenmark Pharmaceuticals Limited Valor: 3195888
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.69%INR 2,291.25
Draegerwerk AG & Co. KGaA
Draegerwerk AG & Co. KGaA Draegerwerk AG & Co. KGaA Valor: 330446
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.67%EUR 116.60
Dyne Therapeutics Inc
Dyne Therapeutics Inc Dyne Therapeutics Inc Valor: 56806425
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.65%USD 16.64